30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cruse Michael

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cruse Michael's trades of Onkure Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-02 2022-09-01
B Purchase
69,091 -21.3%
440.24
US$3,673,958 		69,091 -21.3% 440.24 US$3,673,958
2022-08-31 2022-08-31
B Purchase
22,613 -39.2%
399.61
US$566,646 		22,613 -39.2% 399.61 US$566,646
2022-08-31 2022-08-30
B Purchase
44,573 -17.7%
271.05
US$2,289,428 		44,573 -17.7% 271.05 US$2,289,428
2022-08-31 2022-08-30
B Purchase
975 +3.2%
3.16
US$3,081 		975 +3.2% 3.16 US$3,081
2022-08-31 2022-08-29
B Purchase
1,140 +inf%
3.24
US$3,694 		1,140 +inf% 3.24 US$3,694
2022-08-31 2022-08-29
PP Planned purchase
83 +0.3%
3.24
US$269 		83 +0.3% 3.24 US$269